Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical ivermectin 0.5% for head lice infestation
IRCT2016071320514N5Phase 3Completed
- Sponsor
- Gilaranco
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of ivermectin in pediculosis capitis, sponsored by Gilaranco. Started Oct 2016; status: completed.
02
Drugs
ivermectin
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on IRCT2016071320514N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016071320514N5.